Weight Loss Medications
GLP-1 vs Wegovy
Wegovy IS a GLP-1 agonist. It's the FDA-approved weight loss version of semaglutide (same molecule as Ozempic, higher dose).
Key Point
Wegovy = Semaglutide at 2.4mg weekly, specifically FDA-approved for chronic weight management in adults with obesity or overweight with weight-related conditions.
Wegovy Quick Facts
Average Weight Loss
15-17%
body weight in clinical trials
Dosing
Weekly
subcutaneous injection
Max Dose
2.4mg
vs 1mg for Ozempic
Prescription Required
Wegovy requires a prescription and medical supervision. Common side effects include nausea, diarrhea, vomiting, and constipation, especially during dose escalation.